Growing prevalence of cancer and cancer related diseases drives the market demand for biopsy forceps devices
in the upcoming years. Changing lifestyle patterns, increasing smoking population across the globe and varying
food habits are considered as major causes of cancer. Rising incidences of fatal cancer among patients such as
colorectal cancer, breast cancer, lung cancer, liver cancer, and stomach cancer are projected to boost market
growth. Almost 23.6 million people around the globe are expected to display cancer symptoms by next decade.
Demand for highly effective, safer, and enhanced biopsy procedures is one the rise. Additionally, development
of minimally invasive medical procedures that offers numerous advantages over traditional procedures are
boosting market value of biopsy forceps devices, in the last few years. Minimally invasive medical procedures
offer faster recovery of patients and are less traumatic.
The market is broadly categorized into four major types based on product type such as needle-based biopsy
guns, biopsy guidance systems, biopsy needles, and biopsy forceps. The needle-based biopsy guns is considered
as one of the fastest growing segment in the biopsy forceps market with substantial revenue generation in the
last couple of years. Growing popularity of the needle-based biopsy guns segment is attributed to growing
requirements of these devices to carry out diagnosis of soft tissues of internal organs such as breasts, kidneys,
and lungs. Factors responsible for sustained growth of the needle-based biopsy guns segment include
development of aspiration biopsy syringe guns to perform complex diagnosis procedures.
The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America
has shown major growth in recent years owing to the rise in the implementation of latest technologies in
pharmaceuticals & medicine sector, higher penetration rates of advanced devices like vacuum assisted biopsy
systems, increase in demand for disposable devices from healthcare professionals, and existence of well-
established healthcare infrastructure in the region. Asia-Pacific region is predicted to hold major market share
in the biopsy forceps market with massive growth in forecast period. Countries such as India, China and South
Korea are leading the Asia-Pacific market with increasing healthcare expenditure, growing prevalence of cancer
related diseases, presence of high-unmet patient needs, and significant investment by leading industry players
considering potential growth opportunities in the region.
The key players in the biopsy forceps market are Inard Inc., Carefusion Co., Devicor Medical Products, Inc., DTR
Medical, Ltd., Hologic Inc., C.R. Bard Inc., Biopsy Sciences LLC, and Cardinal Health Inc.
Browse Related Category Market Reports @
https://www.millioninsights.com/industry/medical-devices